Therapeutic Clinical Research
Welcome,         Profile    Billing    Logout  
 5 Trials 
8 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Bhatia, Neal
SCALP1, NCT05910450: A Study to Evaluate the Efficacy and Safety of Clascoterone Solution in Treatment of Male Pattern Hair Loss

Recruiting
3
726
US, RoW
Clascoterone 5% solution, CB-03-01 5% solution, Vehicle solution, Vehicle
Cassiopea SpA, Ergomed PLC, Pharmapace Inc, Canfield Scientific Inc., ICON Clinical Research
Alopecia, Androgenetic
10/24
04/25
TAK-279-PsO-3003, NCT06550076: A Study of TAK-279 in Participants With Moderate-to-Severe Plaque Psoriasis

Recruiting
3
1300
Europe, Canada, Japan, US, RoW
TAK-279
Takeda
Plaque Psoriasis
05/26
05/26
TOGETHER-PsO, NCT06588283: Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Moderate-to-Severe Plaque Psoriasis and Obesity or Overweight

Recruiting
3
250
US
Ixekizumab, LY2439821, Tirzepatide, LY3298176
Eli Lilly and Company
Psoriasis, Obesity
12/25
05/26
TAK-279-3002, NCT06108544: A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 60 Weeks of Treatment With a Withdrawal and Retreatment Period

Active, not recruiting
3
1108
Europe, Canada, US, RoW
TAK-279, Placebo, Apremilast
Takeda
Plaque Psoriasis
12/24
11/25
NCT05442190: Topical SGX302 for Mild-to-Moderate Psoriasis

Recruiting
2
47
US
Hypericin, SGX302, Placebo
Soligenix
Psoriasis, Plaque Psoriasis, Psoriasis Vulgaris
04/25
06/25
VP-315-201, NCT05188729: Open-Label Proof of Concept Study of VP-315 in Basal Cell Carcinoma

Completed
2
92
US
LTX-315 Part 1, VP-315, VP-315 Part 2, LTX-315
Verrica Pharmaceuticals Inc., Instat Clinical Research, HeartcoR Solutions, Myonex, Vial Health Technology, Inc
Basal Cell Carcinoma, Skin Cancer, Cancer of the Skin, Basal Cell, Cancer of the Skin, Carcinoma
04/24
04/24
NCT05244980: A Study of TDM-105795 in Male Subjects With Androgenetic Alopecia (AGA)

Completed
1
32
US
TDM-105795, Placebo
Technoderma Medicines Inc., Therapeutics, Inc.
Alopecia, Androgenetic
11/22
02/23
NCT05478213: Ventricular Tachycardia Mechanisms

Recruiting
N/A
10
US
Monophasic Action Potential (MAP) Catheter, EasyMap catheter
Emory University
Ventricular Tachycardia
03/25
03/25
Panella, Beth
No trials found

Download Options